Six Essential KPIs for Your Patient Adherence Program

Focusing on specific KPIs for adherence programs can help pharma not only impact patient outcomes, but also build better return-on-investment models and adherence-targeted revenue strategies.

HealthPrize Technologies Patient Engagement and Adherence Platform Surpasses One Million Enrolled Users

Enrolled users experience average adherence lifts of 52 percent over baseline, promoted and prompted by frequent engagement over long periods of time

Nasdaq TradeTalks: Pharma’s Untapped Profit Source

HealthPrize CEO Tom Kottler recently spoke with Jill Malandrino, host of Nasdaq’s Trade Talks, about why pharma should look to medication adherence as its new profit source.

Adherence: Addressing Pharma's Last-Mile Problem

Pharma’s continued dependence on tactics such as raising drug prices to hit profit targets just aren’t sustainable long-term. Further, price increases – responsible for 100 percent of pharma’s 2016 earnings per share (EPS) growth – do not improve patient outcomes or save lives.

Boehringer Ingelheim and HealthPrize Expand Successful Digital Patient Support Program

Boehringer Ingelheim and HealthPrize Technologies today announced the expansion of the RespiPoints digital support program to anyone taking one of several Boehringer Ingelheim medicines, including select medicines available in the Respimat inhaler.

HealthPrize Technologies Wins 2018 Frost & Sullivan Technology Leadership Award

The digital adherence and patient engagement platform is recognized by Frost for improving patient outcomes and solving business challenges.

HealthPrize and West Extend Connected Health Partnership

The two companies extend their collaboration to integrate West’s drug delivery systems with HealthPrize’s digital adherence and engagement platform.

Meet HealthPrize at These Spring Conferences

We're packing our bags - and our booth shwag - and getting ready for the Spring season of life science marketing conferences. If you'd like to learn more about HealthPrize, we'd like to learn more about your challenges and goals.

Medication Adherence: Pharma's $637 Billion Opportunity

Medication non-adherence is one of the most serious problems in healthcare, posing a heavy financial impact on all constituencies.

Michael Griffith Joins the HealthPrize Technologies Board of Directors

Former inVentiv executive brings key pharmaceutical services sector experience to HealthPrize’s board.